Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Buying $1000 In MASI: If an investor had bought $1000 of MASI stock 10 years ago, it would be worth $5,655.84 today based on a price of $144.22 for MASI at the time of writing.

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

QSC LLC, which specializes in audio, visual and control systems, has agreed to be acquired by Atlanta-based Acuity Brands ...

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

In its upcoming report, Masimo (MASI) is predicted by Wall Street analysts to post quarterly earnings of $0.84 per share, reflecting an increase of 33.3% compared to the same period last year.

Joshua Stowell is a leading litigator and partner at Knobbe Martens, Orange County's largest intellectual property law firm, ...

A lawsuit against pulse oximeter manufacturers and distributors is starting to create change. But experts say the FDA needs ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

Masimo backs FY24 EPS view $3.80-$4.00, consensus $3.88 Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...